<DOC>
	<DOCNO>NCT01550341</DOCNO>
	<brief_summary>As July , 2014 study aim change . The revised project , call STRIDE2 , longitudinal , non-randomized , observational study individual live HIV dependent opioids . This study fund National Institute Drug Abuse ( R01DA030768 , Altice , PI ; Taxman &amp; Lawson , Co-PIs ) conduct George Mason University , Yale University , Howard University . Those individual originally enrol STRIDE RCT follow 12 month .</brief_summary>
	<brief_title>HIV , Buprenorphine , Criminal Justice System</brief_title>
	<detailed_description>STRIDE2 assist identify monitoring individual ' HIV risk behavior provide resource seek treatment HIV care substance use . The goal STRIDE2 examine difference HIV , drug use , outcomes individual receive treatment versus individual actively use , actively use treatment , individual Methadone , Suboxone , treatment .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>HIV+ Age ≥18 yr Meets DSMIV criterion opioid dependence Has medical entitlement DC Able provide inform consent Able communicate English Spanish Being prescribed opiate medication chronic pain condition express need place chronic pain medical condition document pain condition Currently receive methadone dose 30 mg per day uninterested change buprenorphine AST ALT &gt; 5x upper limit normal ( AST≥175 , ALT≥195 ) Pregnant unwilling use contraception ( include OCPs , patch , DepoProvera , condom , etc . ) Breastfeeding unwilling stop breastfeeding Subject part another pharmacological research study Liver dysfunction ( acute hepatitis , liver failure hepatic dysfunction ) Suicidal ideation Hypersensitivity buprenorphine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Opiate Addiction</keyword>
	<keyword>Drug Dependence</keyword>
	<keyword>Buprenorphine</keyword>
</DOC>